The Association of Metabolic Syndrome and Its Components with Electrocardiogram Parameters and Abnormalities Among an Iranian Rural Population: The Fasa PERSIAN Cohort Study.
P wave
QRS complex
QTc interval
electrocardiogram
metabolic syndrome
Journal
Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
05
2020
accepted:
04
08
2020
entrez:
18
9
2020
pubmed:
19
9
2020
medline:
19
9
2020
Statut:
epublish
Résumé
Metabolic syndrome (MetS) as a set of cardiac risk factors and its growing prevalence is one of the major concerns in different societies. In this study, we aimed to investigate the relationship between Mets and electrocardiogram (ECG) parameters and abnormalities as indicators for subclinical cardiovascular diseases (CVD). In this sub-analysis study, we used the data from Fasa PERSIAN Cohort Study which includes subjects age 35-70 years. Subjects with available ECG data included in the study (n=7002) and subjects with missing data on MetS components and non-sinus rhythm ECG were excluded (n=44). The MetS definition based on the Adult Treatment Panel (ATP) III guidelines and also a 12-lead ECG was obtained from all participants. Our study population (n=6958) showed a mean age of 48.60±9.34 years and also 1656 (24.2%) subjects had MetS. Except for P duration, PR interval and S amplitude in men and P amplitude, S amplitude, Sokolow-Lyon Index, and QT interval in women, other ECG parameters differ significantly between subjects with and without Mets (P<0.05). Also among ECG abnormalities, prolonged P duration (≥120ms), QRS duration (≥100ms), and QTc interval (>450ms in male, >470ms in female) had a significant association with MetS in the total population. Waist circumferences (WC) showed the most count of significant relationship with ECG parameters in both genders. In males, WC more than ATP cut-points had significant associations with prolonged P and QRS duration, and also blood pressure (BP) had significant associations with prolonged P and QRS durations and QTc interval. In females, the MetS component except triglyceride had at least a significant relationship with prolonged P and/or QRS duration. MetS and its component especially WC and BP were associated with ECG parameters and abnormalities. These associations with ECG as a marker of subclinical CVD showed the importance of MetS and each component in our population to monitor in the further longitudinal studies.
Sections du résumé
BACKGROUND
BACKGROUND
Metabolic syndrome (MetS) as a set of cardiac risk factors and its growing prevalence is one of the major concerns in different societies. In this study, we aimed to investigate the relationship between Mets and electrocardiogram (ECG) parameters and abnormalities as indicators for subclinical cardiovascular diseases (CVD).
METHODS
METHODS
In this sub-analysis study, we used the data from Fasa PERSIAN Cohort Study which includes subjects age 35-70 years. Subjects with available ECG data included in the study (n=7002) and subjects with missing data on MetS components and non-sinus rhythm ECG were excluded (n=44). The MetS definition based on the Adult Treatment Panel (ATP) III guidelines and also a 12-lead ECG was obtained from all participants.
RESULTS
RESULTS
Our study population (n=6958) showed a mean age of 48.60±9.34 years and also 1656 (24.2%) subjects had MetS. Except for P duration, PR interval and S amplitude in men and P amplitude, S amplitude, Sokolow-Lyon Index, and QT interval in women, other ECG parameters differ significantly between subjects with and without Mets (P<0.05). Also among ECG abnormalities, prolonged P duration (≥120ms), QRS duration (≥100ms), and QTc interval (>450ms in male, >470ms in female) had a significant association with MetS in the total population. Waist circumferences (WC) showed the most count of significant relationship with ECG parameters in both genders. In males, WC more than ATP cut-points had significant associations with prolonged P and QRS duration, and also blood pressure (BP) had significant associations with prolonged P and QRS durations and QTc interval. In females, the MetS component except triglyceride had at least a significant relationship with prolonged P and/or QRS duration.
CONCLUSION
CONCLUSIONS
MetS and its component especially WC and BP were associated with ECG parameters and abnormalities. These associations with ECG as a marker of subclinical CVD showed the importance of MetS and each component in our population to monitor in the further longitudinal studies.
Identifiants
pubmed: 32943893
doi: 10.2147/DMSO.S263093
pii: 263093
pmc: PMC7467662
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2975-2987Informations de copyright
© 2020 Yazdanpanah et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Electrocardiol. 2013 Jul-Aug;46(4):359.e1-6
pubmed: 23484862
Endocrinol Metab (Seoul). 2016 Mar;31(1):105-12
pubmed: 26676332
Lancet. 1998 Aug 22;352(9128):601-5
pubmed: 9746020
Arch Iran Med. 2014 May;17(5):321-35
pubmed: 24784861
Diabetol Metab Syndr. 2017 May 22;9:40
pubmed: 28539979
J Am Coll Cardiol. 2006 Jan 3;47(1):72-5
pubmed: 16386667
Hypertens Res. 2009 Apr;32(4):289-98
pubmed: 19262490
Diabetes Metab Syndr. 2018 Apr - Jun;12(2):195-201
pubmed: 29203060
Physiol Rev. 2008 Apr;88(2):389-419
pubmed: 18391168
Arch Iran Med. 2019 Apr 01;22(4):204-210
pubmed: 31126179
Diabetes Res Clin Pract. 2003 Jul;61(1):29-37
pubmed: 12849921
Am Heart J. 2014 Aug;168(2):182-8.e1
pubmed: 25066557
Med Hypotheses. 1982 Mar;8(3):261-8
pubmed: 7087823
JNMA J Nepal Med Assoc. 2013 Oct-Dec;52(192):557-62
pubmed: 25327226
World J Cardiovasc Dis. 2012 Apr;2(2):50-56
pubmed: 23515880
Eur Heart J. 2009 Dec;30(24):3055-63
pubmed: 19778928
Cardiovasc J Afr. 2016 Jan-Feb;27(1):16-20
pubmed: 26301945
Am J Med. 2006 Oct;119(10):812-9
pubmed: 17000207
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
J Cardiometab Syndr. 2007 Fall;2(4):267-75
pubmed: 18059210
Herz. 2006 Jun;31(4):305-16
pubmed: 16810470
JAMA. 2015 May 19;313(19):1973-4
pubmed: 25988468
Am J Cardiol. 2000 Apr 1;85(7):908-10, A10
pubmed: 10758940
Obesity (Silver Spring). 2019 Dec;27(12):2076-2083
pubmed: 31657153
Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-225
pubmed: 28639538
Obesity (Silver Spring). 2012 Mar;20(3):666-72
pubmed: 21475136
Atherosclerosis. 2013 Feb;226(2):412-8
pubmed: 23290266
BMC Public Health. 2016 Oct 18;16(1):1090
pubmed: 27756262
Am J Clin Nutr. 2008 Jun;87(6):1876-82
pubmed: 18541580
Metab Syndr Relat Disord. 2012 Apr;10(2):92-7
pubmed: 22053762
J Clin Med. 2019 Sep 23;8(10):
pubmed: 31547597
Nutr Metab Cardiovasc Dis. 2014 Mar;24(3):315-20
pubmed: 24462049
Am J Cardiol. 2018 Mar 1;121(5):570-578
pubmed: 29310809
Diabetes Res Clin Pract. 2007 Aug;77(2):251-7
pubmed: 17234299
J Electrocardiol. 1982 Apr;15(2):115-8
pubmed: 7069326
Heart. 2015 Jan;101(1):44-9
pubmed: 25179964
Am Heart J. 1949 Feb;37(2):161-86
pubmed: 18107386
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
J Clin Lipidol. 2014 May-Jun;8(3):279-86
pubmed: 24793349
Diabetes. 1988 Dec;37(12):1595-607
pubmed: 3056758
Q J Med. 1986 Dec;61(236):1081-90
pubmed: 3310065
Pak J Med Sci. 2018 May-Jun;34(3):626-632
pubmed: 30034428
Clin Exp Hypertens. 2018;40(3):238-243
pubmed: 28872347